www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-1694.Opinion.2-7-2019.pdf

Feb 7, 2019 ... (all the claims) of United States Patent No. ... '239 Patent”) owned by Bristol- Myers Squibb Company ... Momenta Pharm., Inc. v. ... 311 et seq.

www.law360.com/cases/5c8fe34129ae531332fb966f

Parties, docket activity and news coverage of federal case ROMERO v. BRISTOL- MYERS SQUIBB COMPANY et al, case number 3:19-cv-00504, from Florida ...

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... Momenta Pharmaceuticals, Inc. v, Bristol-Myers Squibb Co. ... and covered business method patent review) against a Petitioner (loss of patent ... partes review (IPR) brought by Momenta against all claims of U.S. Patent No.

caselaw.findlaw.com/us-6th-circuit/1878276.html

BRISTOL-MYERS SQUIBB COMPANY; Otsuka America Pharmaceutical, Inc., Defendants-Appellees. ..... Bell Atlantic Corp., et al. v. Twombly, 550 U.S. 544, 555, ...

www.ftc.gov/enforcement/cases-proceedings/0110046/bristol-myers-squibb-company-matter

May 25, 2004 ... Bristol-Myers Squibb Company (BMS) settled charges that it engaged in illegal business practices to delay the entry of three low price generic ...